Literature DB >> 16844304

Aberrant trafficking of a proteolipid protein in a mild Pelizaeus-Merzbacher disease.

S Koizume1, S Takizawa, K Fujita, N Aida, S Yamashita, Y Miyagi, H Osaka.   

Abstract

Pelizaeus-Merzbacher disease (PMD) is a rare X-linked leukodystrophy caused by proteolipid protein 1 (PLP1) gene mutations. Previous studies indicated that proteolipid proteins (PLPs) with disease-associated mutations are misfolded and trapped in the endoplasmic reticulum (ER) during transportation to the cell surface, which eventually leads to oligodendrocyte cell death in PMD. Here we report a PMD patient with a very mild phenotype carrying a novel mutation (485G-->T) in exon 4 of the PLP1 gene that causes a Trp(162)Leu substitution in the protein. We also investigated intracellular trafficking of this mutant PLP in COS-7 cells. Transiently transfected mutant PLP(W162L) fused to an enhanced green fluorescent protein (EGFP) or a short peptide tag was not carried to the plasma membrane. However, in contrast to previous studies, this mutant PLP was not retained in the ER, indicating an escape of the newly translated protein from the quality control machinery. We also found that the mutant PLP accumulated in the nuclear envelope (NE) in a time-dependent manner. This mutant PLP, with its distribution outside the ER and a very mild phenotype, supports the idea that accumulation of misfolded mutant protein in the ER causes the severe phenotype of PMD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16844304     DOI: 10.1016/j.neuroscience.2006.05.067

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  8 in total

1.  Identification and functions of amino acid residues in PotB and PotC involved in spermidine uptake activity.

Authors:  Kyohei Higashi; Yoshiharu Sakamaki; Emiko Herai; Risa Demizu; Takeshi Uemura; Sunil D Saroj; Risa Zenda; Yusuke Terui; Kazuhiro Nishimura; Toshihiko Toida; Keiko Kashiwagi; Kazuei Igarashi
Journal:  J Biol Chem       Date:  2010-10-11       Impact factor: 5.157

2.  Depletion of molecular chaperones from the endoplasmic reticulum and fragmentation of the Golgi apparatus associated with pathogenesis in Pelizaeus-Merzbacher disease.

Authors:  Yurika Numata; Toshifumi Morimura; Shoko Nakamura; Eriko Hirano; Shigeo Kure; Yu-Ich Goto; Ken Inoue
Journal:  J Biol Chem       Date:  2013-01-23       Impact factor: 5.157

3.  Differences in endoplasmic-reticulum quality control determine the cellular response to disease-associated mutants of proteolipid protein.

Authors:  Peristera Roboti; Eileithyia Swanton; Stephen High
Journal:  J Cell Sci       Date:  2009-10-13       Impact factor: 5.285

4.  miR-23 regulation of lamin B1 is crucial for oligodendrocyte development and myelination.

Authors:  Shu-Ting Lin; Ying-Hui Fu
Journal:  Dis Model Mech       Date:  2009-02-02       Impact factor: 5.758

5.  Targeted metabolomic analyses of cellular models of pelizaeus-merzbacher disease reveal plasmalogen and myo-inositol solute carrier dysfunction.

Authors:  Paul L Wood; Tara Smith; Lindsay Pelzer; Dayan B Goodenowe
Journal:  Lipids Health Dis       Date:  2011-06-17       Impact factor: 3.876

6.  In vitro and in vivo plasmalogen replacement evaluations in rhizomelic chrondrodysplasia punctata and Pelizaeus-Merzbacher disease using PPI-1011, an ether lipid plasmalogen precursor.

Authors:  Paul L Wood; M Amin Khan; Tara Smith; Greg Ehrmantraut; Wei Jin; Wei Cui; Nancy E Braverman; Dayan B Goodenowe
Journal:  Lipids Health Dis       Date:  2011-10-18       Impact factor: 3.876

7.  Drug screening for Pelizaeus-Merzbacher disease by quantifying the total levels and membrane localization of PLP1.

Authors:  Takeshi Kouga; Shiro Koizume; Shiho Aoki; Eriko Jimbo; Takanori Yamagata; Ken Inoue; Hitoshi Osaka
Journal:  Mol Genet Metab Rep       Date:  2019-05-07

8.  Chemical Screening Identifies Enhancers of Mutant Oligodendrocyte Survival and Unmasks a Distinct Pathological Phase in Pelizaeus-Merzbacher Disease.

Authors:  Matthew S Elitt; H Elizabeth Shick; Mayur Madhavan; Kevin C Allan; Benjamin L L Clayton; Chen Weng; Tyler E Miller; Daniel C Factor; Lilianne Barbar; Baraa S Nawash; Zachary S Nevin; Angela M Lager; Yan Li; Fulai Jin; Drew J Adams; Paul J Tesar
Journal:  Stem Cell Reports       Date:  2018-08-23       Impact factor: 7.765

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.